Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novartis quietly returns a key antibiotic to US market

There is some good news in the world of antibiotics. Novartis quietly snagged supplemental FDA approval for its drug Lamprene over the summer, transitioning a decades-old leprosy drug to the commercial market, which may boost ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 13 October →